The direct inhibition of c-Myc has been shown to trigger rapid tumor regression in mice, which may be a viable therapeutic approach [32], and moreover, targeting IL-8 may also be a precise and reasonable strategy to inhibit tumor angiogenesis. This evidence concerns the gene CXCL8 and neoplasm.